SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $482,000 | -13.8% | 18,080 | -0.3% | 0.01% | -15.4% |
Q2 2021 | $559,000 | +17.9% | 18,140 | +0.2% | 0.01% | +8.3% |
Q1 2021 | $474,000 | +13.9% | 18,100 | +9.6% | 0.01% | +9.1% |
Q4 2020 | $416,000 | +20.9% | 16,520 | +31.8% | 0.01% | +10.0% |
Q3 2019 | $344,000 | -18.1% | 12,530 | -1.3% | 0.01% | -16.7% |
Q2 2019 | $420,000 | -11.9% | 12,690 | -6.8% | 0.01% | -14.3% |
Q1 2019 | $477,000 | +5.1% | 13,620 | -0.4% | 0.01% | 0.0% |
Q4 2018 | $454,000 | -47.8% | 13,680 | -20.7% | 0.01% | -36.4% |
Q3 2018 | $869,000 | -19.2% | 17,260 | -4.0% | 0.02% | -24.1% |
Q2 2018 | $1,076,000 | +36.4% | 17,980 | +4.4% | 0.03% | +45.0% |
Q1 2018 | $789,000 | +4.9% | 17,220 | -8.7% | 0.02% | +11.1% |
Q4 2017 | $752,000 | -12.4% | 18,870 | -12.0% | 0.02% | -18.2% |
Q3 2017 | $858,000 | 0.0% | 21,450 | 0.0% | 0.02% | 0.0% |
Q3 2016 | $858,000 | – | 21,450 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |